Blueprint Medicines’ Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting
— HARBOR Part 1 trial data in indolent systemic mastocytosis showed elenestinib was well-tolerated with broad symptom improvement, supporting further development to expand and extend company’s SM franchise leadership — CAMBRIDGE, Mass., Dec. 9, 2023 /PRNewswire/ — Blueprint
Last Legend Off the Line: 2023 Chrysler 300C Ends Production
AUBURN HILLS, Mich., Dec. 9, 2023 /PRNewswire/ — Final 2023 Chrysler 300C model rolls off production line at Brampton (Ontario) Assembly PlantBrampton team members commemorate the final production of the HEMI®-powered vehicle — a Velvet Red 2023 Chrysler 300CFinal production of the 2023 Chr
The NDC Partnership Joins the COP28 and CBD COP15 Presidencies and Nearly 30 Countries and Coalitions Advancing Integrated Action for Climate and Nature
DUBAI, UAE, Dec. 9, 2023 /PRNewswire/ — The NDC Partnership, the United Arab Emirates as the United Nations Framework Convention on Climate Change (UNFCCC) COP28 Presidency, the People’s Republic of China as the United Nations Convention on Biological Diversity (CBD) COP15 Presidency, an
Bulleit Frontier Whiskey takes on Miami to celebrate the first year of the Bulleit Pioneer Project
NEW YORK, Dec. 9, 2023 /PRNewswire/ — Last night, Bulleit Frontier Whiskey celebrated the first year of The Bulleit Pioneer Project — its multi-year commitment to championing and amplifying those breaking new ground in culture. This anniversary event brought together pioneers across art, mus
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
– Data from Phase 1/2 EPCORE™ NHL-1 study show patients treated with epcoritamab experienced 82% overall response rates (ORR) including 63% complete response (CR) rates as presented at the 65th American Society of Hematology (ASH) congress– Follicular lymphoma is the second most co
Fresh cut cantaloupe products recalled due to Salmonella
OTTAWA, ON, Dec. 08, 2023 /CNW/ – Product: Fresh cut cantaloupe products Issue: Food – Microbial Contamination – Salmonella Distribution: National See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)
ROSEN, A LEADING LAW FIRM, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – PAYC
NEW YORK, Dec. 9, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Paycom Software, Inc. (NYSE: PAYC) between May 3, 2023 and November 1, 2023, both dates inclusive (the “Class Period”), of the important January
Minister Guilbeault delivers Canada’s national statement at COP28
Speaking notes for theHonourable Steven Guilbeault, Minister of Environment and Climate Change December 9, 2023 Location: B8 – Al Waha Theatre Check Against Delivery DUBAI, United Arab Emirates, Dec. 9, 2023 /CNW/ – Thank you, Mr. President. Your Excellencies, I am very pleased to present
Prism Specialties Experts Share How to Prepare Your Home for the Winter Season
Specialty restoration franchise leader urges homeowners to get ahead of winter weather to avoid storm damage LIVONIA, Mich., Dec. 9, 2023 /PRNewswire/ — With freezing temperatures right around the corner, it is impossible to ignore that the harsh winter season is upon us. Prism Specialties, th
L.N. Dhamani: Founder Dhamani Jewels Group – A Life Dedicated to Gems & Fine Jewellery
DUBAI, UAE, Dec. 9, 2023 /PRNewswire/ — L.N. Dhamani, a Pioneer of the gems & Jewellery industry, passed away on 1st December 2023 at the age of 70. Born in Jaipur, India, L. N. Dhamani developed a passion for gemstones at a young age. He established his company, Dhamani, in 1969 at the ag
